date:Aug 27, 2018
facturing capacity, Biocatalysts recently launched MetXtra, a unique enzyme discovery platform that provides a fast and cost-effective approach to novel enzyme development. Add into this mix the recent purchase of Biocatalysts by BRAIN AG, which further strengthens the companys offering and gives customers access to an unparalleled range of capabilities in enzyme discovery.
Daren Bryce, Commercial Director at Biocatalysts, comments: This represents a very exciting time in the speciality enzyme